A Semmelweis Egyetem extracorporalis membránoxigenizációs programja - Az 5 éves Városmajori-eredmények függvényében

Translated title of the contribution: The Semmelweis University extracorporeal membrane oxygenation program - 5 years' results and perspectives

Hartyánszky István, Koppányi Ádám, Szabolcs Zoltán, F. Horkay, Fazekas Levente, Hüttl Tivadar, Pólos Miklós, Daróczi László, Koszegi Andrea, Benke Kálmán, Tóth Roland, Kovács Péter, Barabás János Imre, Németh Endre, Édes István Ferenc, B. Merkely

Research output: Contribution to journalReview article

Abstract

The mechanical circulatory support (MCS) program of the Semmelweis University Heart and Vascular Centre has become established over the last five years. The main requirements of our MCS program to be developed first were the Heart Transplantation and Heart Failure Intensive Care Unit and a well trained medical team. The wide range of mechanical circulatory support devices provides suitable background for the adequate treatment of our patients in all indications. In this review, we present our results related to extracorporeal membrane oxygenation (ECMO) supports performed in the last five years. Between 2012 and 2017, we applied MCS support in 140 cases, among them 111patients received ECMO support. The leading indications of ECMO support were the following: Primary graft failure after heart transplantation (33 cases), postcardiotomy cardiogenic shock (18 patients), acute decompensation of end-stage heart failure (14 patients), acute myocardial infarction complicated with refractory cardiogenic shock (37 patients), cardiogenic shock developed after transcatheter aortic valve implantation (3 patients), malignant arrhythmia due to drug intoxication (1 patient) and acute respiratory distress syndrome (4 cases). The mortality of patients receiving ECMO support was 46%. The analysis of the results of ECMO support needs to change our approach. The mortality results show that we lost the half of our patients. However, the mortality in the conventionally treated patients would have been 100% without ECMO. In fact, we could save the life of half of these patients.

Original languageHungarian
Pages (from-to)1876-1881
Number of pages6
JournalOrvosi Hetilap
Volume159
Issue number46
DOIs
Publication statusPublished - Nov 1 2018

Fingerprint

Extracorporeal Membrane Oxygenation
Cardiogenic Shock
Heart Transplantation
Mortality
Heart Failure
Adult Respiratory Distress Syndrome
Blood Vessels
Intensive Care Units
Cardiac Arrhythmias
Myocardial Infarction
Transplants
Equipment and Supplies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A Semmelweis Egyetem extracorporalis membránoxigenizációs programja - Az 5 éves Városmajori-eredmények függvényében. / István, Hartyánszky; Ádám, Koppányi; Zoltán, Szabolcs; Horkay, F.; Levente, Fazekas; Tivadar, Hüttl; Miklós, Pólos; László, Daróczi; Andrea, Koszegi; Kálmán, Benke; Roland, Tóth; Péter, Kovács; Imre, Barabás János; Endre, Németh; Ferenc, Édes István; Merkely, B.

In: Orvosi Hetilap, Vol. 159, No. 46, 01.11.2018, p. 1876-1881.

Research output: Contribution to journalReview article

István, H, Ádám, K, Zoltán, S, Horkay, F, Levente, F, Tivadar, H, Miklós, P, László, D, Andrea, K, Kálmán, B, Roland, T, Péter, K, Imre, BJ, Endre, N, Ferenc, ÉI & Merkely, B 2018, 'A Semmelweis Egyetem extracorporalis membránoxigenizációs programja - Az 5 éves Városmajori-eredmények függvényében', Orvosi Hetilap, vol. 159, no. 46, pp. 1876-1881. https://doi.org/10.1556/650.2018.31298
István, Hartyánszky ; Ádám, Koppányi ; Zoltán, Szabolcs ; Horkay, F. ; Levente, Fazekas ; Tivadar, Hüttl ; Miklós, Pólos ; László, Daróczi ; Andrea, Koszegi ; Kálmán, Benke ; Roland, Tóth ; Péter, Kovács ; Imre, Barabás János ; Endre, Németh ; Ferenc, Édes István ; Merkely, B. / A Semmelweis Egyetem extracorporalis membránoxigenizációs programja - Az 5 éves Városmajori-eredmények függvényében. In: Orvosi Hetilap. 2018 ; Vol. 159, No. 46. pp. 1876-1881.
@article{6c15826017b749368e48acce8462bf70,
title = "A Semmelweis Egyetem extracorporalis membr{\'a}noxigeniz{\'a}ci{\'o}s programja - Az 5 {\'e}ves V{\'a}rosmajori-eredm{\'e}nyek f{\"u}ggv{\'e}ny{\'e}ben",
abstract = "The mechanical circulatory support (MCS) program of the Semmelweis University Heart and Vascular Centre has become established over the last five years. The main requirements of our MCS program to be developed first were the Heart Transplantation and Heart Failure Intensive Care Unit and a well trained medical team. The wide range of mechanical circulatory support devices provides suitable background for the adequate treatment of our patients in all indications. In this review, we present our results related to extracorporeal membrane oxygenation (ECMO) supports performed in the last five years. Between 2012 and 2017, we applied MCS support in 140 cases, among them 111patients received ECMO support. The leading indications of ECMO support were the following: Primary graft failure after heart transplantation (33 cases), postcardiotomy cardiogenic shock (18 patients), acute decompensation of end-stage heart failure (14 patients), acute myocardial infarction complicated with refractory cardiogenic shock (37 patients), cardiogenic shock developed after transcatheter aortic valve implantation (3 patients), malignant arrhythmia due to drug intoxication (1 patient) and acute respiratory distress syndrome (4 cases). The mortality of patients receiving ECMO support was 46{\%}. The analysis of the results of ECMO support needs to change our approach. The mortality results show that we lost the half of our patients. However, the mortality in the conventionally treated patients would have been 100{\%} without ECMO. In fact, we could save the life of half of these patients.",
keywords = "Artificial heart, Ecmo, Mechanical circulatory support",
author = "Harty{\'a}nszky Istv{\'a}n and Kopp{\'a}nyi {\'A}d{\'a}m and Szabolcs Zolt{\'a}n and F. Horkay and Fazekas Levente and H{\"u}ttl Tivadar and P{\'o}los Mikl{\'o}s and Dar{\'o}czi L{\'a}szl{\'o} and Koszegi Andrea and Benke K{\'a}lm{\'a}n and T{\'o}th Roland and Kov{\'a}cs P{\'e}ter and Imre, {Barab{\'a}s J{\'a}nos} and N{\'e}meth Endre and Ferenc, {{\'E}des Istv{\'a}n} and B. Merkely",
year = "2018",
month = "11",
day = "1",
doi = "10.1556/650.2018.31298",
language = "Hungarian",
volume = "159",
pages = "1876--1881",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "46",

}

TY - JOUR

T1 - A Semmelweis Egyetem extracorporalis membránoxigenizációs programja - Az 5 éves Városmajori-eredmények függvényében

AU - István, Hartyánszky

AU - Ádám, Koppányi

AU - Zoltán, Szabolcs

AU - Horkay, F.

AU - Levente, Fazekas

AU - Tivadar, Hüttl

AU - Miklós, Pólos

AU - László, Daróczi

AU - Andrea, Koszegi

AU - Kálmán, Benke

AU - Roland, Tóth

AU - Péter, Kovács

AU - Imre, Barabás János

AU - Endre, Németh

AU - Ferenc, Édes István

AU - Merkely, B.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - The mechanical circulatory support (MCS) program of the Semmelweis University Heart and Vascular Centre has become established over the last five years. The main requirements of our MCS program to be developed first were the Heart Transplantation and Heart Failure Intensive Care Unit and a well trained medical team. The wide range of mechanical circulatory support devices provides suitable background for the adequate treatment of our patients in all indications. In this review, we present our results related to extracorporeal membrane oxygenation (ECMO) supports performed in the last five years. Between 2012 and 2017, we applied MCS support in 140 cases, among them 111patients received ECMO support. The leading indications of ECMO support were the following: Primary graft failure after heart transplantation (33 cases), postcardiotomy cardiogenic shock (18 patients), acute decompensation of end-stage heart failure (14 patients), acute myocardial infarction complicated with refractory cardiogenic shock (37 patients), cardiogenic shock developed after transcatheter aortic valve implantation (3 patients), malignant arrhythmia due to drug intoxication (1 patient) and acute respiratory distress syndrome (4 cases). The mortality of patients receiving ECMO support was 46%. The analysis of the results of ECMO support needs to change our approach. The mortality results show that we lost the half of our patients. However, the mortality in the conventionally treated patients would have been 100% without ECMO. In fact, we could save the life of half of these patients.

AB - The mechanical circulatory support (MCS) program of the Semmelweis University Heart and Vascular Centre has become established over the last five years. The main requirements of our MCS program to be developed first were the Heart Transplantation and Heart Failure Intensive Care Unit and a well trained medical team. The wide range of mechanical circulatory support devices provides suitable background for the adequate treatment of our patients in all indications. In this review, we present our results related to extracorporeal membrane oxygenation (ECMO) supports performed in the last five years. Between 2012 and 2017, we applied MCS support in 140 cases, among them 111patients received ECMO support. The leading indications of ECMO support were the following: Primary graft failure after heart transplantation (33 cases), postcardiotomy cardiogenic shock (18 patients), acute decompensation of end-stage heart failure (14 patients), acute myocardial infarction complicated with refractory cardiogenic shock (37 patients), cardiogenic shock developed after transcatheter aortic valve implantation (3 patients), malignant arrhythmia due to drug intoxication (1 patient) and acute respiratory distress syndrome (4 cases). The mortality of patients receiving ECMO support was 46%. The analysis of the results of ECMO support needs to change our approach. The mortality results show that we lost the half of our patients. However, the mortality in the conventionally treated patients would have been 100% without ECMO. In fact, we could save the life of half of these patients.

KW - Artificial heart

KW - Ecmo

KW - Mechanical circulatory support

UR - http://www.scopus.com/inward/record.url?scp=85056695867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056695867&partnerID=8YFLogxK

U2 - 10.1556/650.2018.31298

DO - 10.1556/650.2018.31298

M3 - Review article

C2 - 30450938

AN - SCOPUS:85056695867

VL - 159

SP - 1876

EP - 1881

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 46

ER -